C&G Editor in Chief, Erin Harris

  1. Video Clips From Cell & Gene Live: Optimizing Your Cold Chain For Cell Therapies 11/30/2023

    For your convenience, we’ve broken down our Cell & Gene Live, Optimizing Your Cold Chain for Cell Therapies, into bite-size video clips by topic.

  2. A Sneak Peek At Providence Therapeutics On Cell & Gene: The Podcast 11/29/2023

    On an upcoming episode of Cell & Gene: The Podcast, I talk to Robert Georgantas III, Ph.D., of Providence Therapeutics, about their mRNA vaccine therapies. Here's a preview of our conversation.

  3. Vor Bio Shares Progress For Patients with AML 11/17/2023

    I talked to Dr. Robert Ang, President and Chief Executive Officer at Vor Bio about the company's VBP101 study for trem-cel in patients with acute myeloid leukemia (AML)

  4. The Eye: A Candidate For Modifier Gene Therapy 11/17/2023

    Ocugen's Chairman, CEO and Co-founder, Shankar Musunuri ,Ph.D., MBA, provides an update on OCU400 and other ongoing trials, why the eye is a good target for gene therapy, the outlook for retinal gene therapy, and more.

  5. Video Clips From Cell & Gene Live: Regulating The CGT Workflow To Improve Patient Safety 10/31/2023

    Here is a breakdown of original 60-minute Cell & Gene Live, Regulating the CGT Workflow to Improve Patient Safety, into video segments by topic.

  6. A Sneak Peek At REGENXBIO On Cell & Gene: The Podcast 10/30/2023

    REGENXBIO's CEO, President, and Director, Ken Mills and I sat down to record an upcoming episode of Cell & Gene: The Podcast. Here's a sneak peak of the episode.

  7. Highlights from In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg 10/27/2023

    Umoja Biopharma’s Dr. Andrew Scharenberg joined me as my guest on a recent episode of Cell & Gene: The Podcast to discuss the evolution of in vivo CAR-T cell therapeutics. Here are highlights from our conversation. 

  8. ARM’s 2023 Meeting On The Mesa: Data, Ethics, And More 10/19/2023

    ARM's 2023 Meeting on the Mesa was chock full of informative sessions, impactful conversations, partnering opportunities, and peer networking. Here's a brief recap.

  9. September's Top Content On Cell & Gene 9/29/2023

    Here is a glimpse of the impactful content, in various formats, Cell & Gene delivered this month.

  10. Dr. Jim Wilson At LSPA’s Life Sciences Future Conference 9/28/2023

    LSPA's Life Science Future event included a plenary session featuring Jim Wilson Ph.D., M.D., Director, Gene Therapy Program Professor of Medicine and Pediatrics, Perelman School of Medicine at the University of Pennsylvania. Here's a recap of that session.